AI assistant
Tectonic Therapeutic, Inc. — Director's Dealing 2025
Sep 29, 2025
33251_dirs_2025-09-29_51aca4be-fd6c-4d10-b30a-0e2fb8a35dd3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Tectonic Therapeutic, Inc. (TECX)
CIK: 0001681087
Period of Report: 2025-09-25
Reporting Person: McNamara Peter (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-25 | Common Stock | A | 4550 | — | Acquired | 33879 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-09-25 | Employee Stock Option (Right to Buy) | $14.71 | A | 8260 | Acquired | 2035-09-24 | Common Stock (8260) | Direct |
Footnotes
F1: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of September 25, 2026, September 25, 2027 and September 25, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2: The shares subject to the option vest in 48 equal monthly installments beginning on October 25, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.